Detalhe da pesquisa
1.
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study.
Breast Cancer Res Treat
; 168(2): 389-399, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29230663
2.
The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resection.
Sci Rep
; 8(1): 2535, 2018 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29416061